BPC-157 for dogs: What the Evidence Shows
What is known about bpc-157 for dogs: veterinary studies, approval status for animals, and the questions to ask your vet.
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
At a glance
- Animal
- Dogs
- Evidence in dogs
- 1 study in dogs
- Status in people
- PCAC voted 8–6 for 503A (Jul 2026)
- Searches per month
- 1,310
Evidence
What is known in dogs
Outcomes from published studies that included dogs, quoted from each abstract. Studies only in people or rodents are not evidence for dogs and are left out.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Elimination half-life | Elimination half-life of BPC157 was under 30 minutes in rats and beagle dogs, with linear pharmacokinetics. | Animal · rat, beagle dog (not a human result) | Frontiers in pharmacology 2022, PMID 36588717 |
| Bioavailability after IM injection | Intramuscular bioavailability was approximately 14%-19% in rats and 45%-51% in beagle dogs. | Animal · rat, beagle dog (not a human result) | Frontiers in pharmacology 2022, PMID 36588717 |
Do not give dogs a product meant for people, or one sold “for research use only”. Doses, safety and side effects differ by species. Ask your vet first.
Your vet
Questions to ask your vet
- Is there an approved veterinary product for this condition?
- Has this been studied in my pet's species, and at what dose?
- What side effects or interactions should I watch for?
- How will we know whether it is working, and when do we stop?
What people search
- bpc 157 for dogs1,300/mo
- bpc157 dosage for dogs10/mo
US monthly searches, Google Keyword Planner, Oct 2026. Shown so you can see which questions this page answers.
Sources
- 1Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Frontiers in pharmacology · 2022PMID 36588717Accessed 2 Oct 2026
Found an error? Report a correction.